ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
02 Sep 2020

Acarix two largest shareholders transfer subscription rights free of charge – extends the subscription period

Press release Malmö, September 2, 2020   Acarix two largest shareholders transfer subscription rights free of charge –extends the su...
Continue reading
author-avatar acarix
Press
August 6, 2024
31 Aug 2020

Acarix VD Per Persson presenterade på Redeye

PressmeddelandeMalmö, Sverige, 31 augusti 2020 Acarix VD Per Persson presenterade på Redeye Vid en investerarpresentation på Redeye d...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2020

Last patient included in Acarix’s exploratory heart failure study SEISMO

Press releaseMalmö, Sweden May 11, 2020 Last patient included in Acarix’s exploratory heart failure study SEISMO Acarix AB (publ) t...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2020

Sista patienten inkluderad i den undersökande hjärtsviktstudien SEISMO

Pressmeddelande Malmö, Sverige, 11 maj 2020 Sista patienten inkluderad i den undersökande hjärtsviktstudien SEISMO Acarix AB (pub...
Continue reading
author-avatar acarix
Press
August 6, 2024
12 Mar 2020

Acarix får återkoppling från tyska myndigheter gällande ansökan om kostnadsersättning

Pressmeddelande Malmö, Sverige, 12 mars 2020 Acarix får återkoppling från tyska myndigheter gällande ansökan om kostnadsersättning A...
Continue reading
author-avatar acarix
Press
August 6, 2024
12 Mar 2020

Acarix receives feedback on German reimbursement submission

Press releaseMalmö, Sweden March 12, 2020 Acarix receives feedback on German reimbursement submission Acarix AB (publ) today announ...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Feb 2020

Första patienten inkluderad i den nya kliniska studien FILTER-SCAD med sammanlagt 2 000 patienter

Pressmeddelande Malmö, Sverige, 18 februari 2020 Första patienten inkluderad i den nya kliniska studien FILTER-SCAD med sammanlagt 2 ...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Feb 2020

First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients

Press release Malmö, Sweden February 18, 2020 First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients ...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Jan 2020

First patients with the CADScor®System in the UK

Press release Malmö, Sweden January 14, 2020 First patients with the CADScor®System in the UK Acarix AB (publ) (ACARIX: FN Stockhol...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Jan 2020

Första patienterna utvärderas med CADScor®System i Storbritannien

Pressmeddelande Malmö, Sverige, 14 januari, 2020 Första patienterna utvärderas med CADScor®System i Storbritannien Acarix AB (publ) ...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Dec 2019

Acarix AB: Redeye initiates coverage of Acarix

Redeye initiates coverage of Acarix. The company's significant potential hinges on its CADScor system's invention of coronary...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Dec 2019

Acarix submits FDA application

Press release Malmö, Sweden 16 December, 2019 Acarix submits FDA application Acarix AB (publ) (ACARIX: FN Stockholm) today announced...
Continue reading
  • «
  • ‹
  • 15
  • 16
  • 17
  • 18
  • 19
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.